DISSECTING THE MOLECULAR BASIS OF POTENT HBF INDUCTION BY BMS-986470: A MECHANISTIC STUDY OF ZBTB7A/WIZ DUAL DEGRADATION
EHA Library, Yan Kai, 4208913
BIVENTRICULAR REMODELING WITH PRESERVED MYOCARDIAL DEFORMATION IN PEDIATRIC SICKLE CELL DISEASE: SPECKLE-TRACKING ECHOCARDIOGRAPHY AND LONGITUDINAL ASSESSMENT
EHA Library, Miguel R. Abboud, 4208914
A METHOD FOR MONITORING RED CELL ENGRAFTMENT POST BONE MARROW TRANSPLANT FOR SICKLE CELL DISEASE
EHA Library, Azalea Khan, 4208915
LONGITUDINAL EFFECT OF HYDROXYUREA AND CHRONIC EXCHANGE TRANSFUSION THERAPIES ON ECHOCARDIOGRAPHIC PARAMETERS OF SICKLE CELL CARDIOMYOPATHY
EHA Library, Jackie Queen, 4208916
CO-DESIGNING A CULTURALLY-TAILORED SELF-MANAGEMENT TOOLBOX FOR UNIVERSITY STUDENTS WITH SICKLE CELL DISEASE IN SAUDI ARABIA: INTEGRATED MRC 2021 FRAMEWORK AND PERSON-BASED APPROACH
EHA Library, Reham Almabadi, 4208917
SHIFTING ATTRIBUTION OF SICKLE CELL DISEASE ON US DEATH CERTIFICATES: A NATIONAL MULTIPLE CAUSE-OF-DEATH ANALYSIS, 2003–2024
EHA Library, Hala Soomro, 4208918
ADVERSE MATERNAL AND PERINATAL OUTCOMES ASSOCIATED WITH SICKLE CELL TRAIT IN PREGNANCY: A SYSTEMATIC REVIEW AND META-ANALYSIS
EHA Library, Luisa Medeiros Visentini, 4208922
TARGETING THE COMPLEMENT ALTERNATIVE PATHWAY ATTENUATES ACUTE VASO-OCCLUSIVE CRISIS IN SICKLE CELL DISEASE.
EHA Library, Thiago Maciel, 4208924
A NOVEL, CLINICALLY APPLIED SCORING SYSTEM FOR FAT EMBOLISM SYNDROME IN SICKLE CELL DISEASE
EHA Library, Abdulrahman Nasiri, 4208925
IMPROVING RETINAL SCREENING IN SICKLE CELL DISEASE USING A NOVEL IN-OFFICE SCAN (A QUALITY IMPROVEMENT INITIATIVE)
EHA Library, Julie Kanter, 4208926
OSTEO-ARTICULAR INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE IN PARIS: A RETROSPECTIVE STUDY
EHA Library, Joséphine Brice, 4208929
BONE DISEASE IN ADULTS WITH THALASSAEMIA: CHARACTERISTICS, INVESTIGATION AND MANAGEMENT INSIGHTS FROM A TERTIARY SERVICE IN THE UK
EHA Library, Chloe Merrion, 4208933
EFFICACY AND SAFETY OF ALTERNATING DEFERIPRONE AND DEFERASIROX COMBINATION CHELATION THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA
EHA Library, Nihan Avcu Oral, 4208938
GENETIC TESTING IN THE DIAGNOSIS OF CONGENITAL ERYTHROCYTOSIS: A REVIEW OF >1700 REFERRALS
EHA Library, Rachel Mayhew, 4208948
WHOLE-GENOME SEQUENCING IN THE DIAGNOSTIC EVALUATION OF PATIENTS WITH SUSPECTED HEREDITARY ANEMIA
EHA Library, Thomas Doeven, 4208949
DXO-1801, A HEPATOCYTE-TARGETED GALNAC-SIRNA, DEMONSTRATES HEPCIDIN PATHWAY MODULATION, IRON MOBILIZATION, AND A FAVORABLE SAFETY PROFILE IN NON-HUMAN PRIMATES
EHA Library, Lilach Steiner, 4208952
IN VIVO CHARACTERIZATION OF FERRITIN H AND L SUBUNITS IN SERUM-DERIVED EXTRACELLULAR VESICLES ACROSS DIFFERENT IRON METABOLISM DISORDERS
EHA Library, Fabiana Busti, 4208953
SERVICE EVALUATION OF PRE OPERATIVE ANAEMIA OPTIMISATION IN NHS AND PRIVATE PATIENTS
EHA Library, Silvia Lovato, 4208956
PERIPHERAL BLOOD MNGS VERSUS BLOOD CULTURE FOR POLYMICROBIAL BLOODSTREAM INFECTIONS IN HEMATOLOGICAL MALIGNANCY: A COMPARISON OF DIAGNOSTIC YIELD AND CLINICAL IMPACT
EHA Library, Rong Fu, 4208958
RAPID DIAGNOSTICS AND TARGETED COLONIZATION MANAGEMENT FOR CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN PEDIATRIC ONCOLOGY: IMPACT ON CLINICAL OUTCOMES
EHA Library, Sally Mahfouz, 4208960
INTEGRATIVE BIOINFORMATIC AND REAL-WORLD DATA ANALYSIS REVEAL MECHANISTIC ASSOCIATIONS BETWEEN LETERMOVIR PROPHYLAXIS AND EBV REACTIVATION AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Zhangjie Chen, 4208962
CD38HIGH ΓΔ T CELLS EXHIBIT AN EXHAUSTED PHENOTYPE AND PREDICT PROGRESSION TO PTLD FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Zhifan Zhao, 4208965
INCORPORATION OF RITUXIMAB INTO CONDITIONING PREVENTS EBV INFECTION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION DURING THE ERA OF LETERMOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS
EHA Library, xiaoning wang, 4208967
GENOMIC DETERMINANTS AND CLINICAL IMPACT OF CARBAPENEM-RESISTANT INFECTIONS IN FEBRILE NEUTROPENIA AMONG PATIENTS WITH ACUTE LEUKEMIA: A WHOLE-GENOME SEQUENCING STUDY
EHA Library, Uttam Kumar Nath, 4208968
LAMIVUDINE PROPHYLAXIS FOR PREVENTION OF HEPATITIS B VIRUS REACTIVATION IN HEMATOLOGIC PATIENTS UNDERGOING IMMUNOSUPPRESSIVE THERAPIES: A SINGLE-CENTER EXPERIENCE
EHA Library, Gianmarco Favrin, 4208976
CAN SURVEILLANCE CULTURE-GUIDED TARGETED ANTIBIOTIC THERAPY IMPROVE TREATMENT OUTCOMES OF FEBRILE NEUTROPENIA IN ACUTE LEUKEMIA PATIENTS ON INTENSIVE CHEMOTHERAPY? SINGLE-CENTER EXPERIENCE FROM INDIA
EHA Library, Uttam Kumar Nath, 4208977
DYNAMIC WHOLE-BLOOD TRANSCRIPTOMIC CHARACTERISTICS OF INFECTION EVOLUTION IN HEMATOLOGIC MALIGNANCY PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA
EHA Library, Dairong Xie, 4208978
EFFICACY AND SAFETY OF CIDOFOVIR FOR ADENOVIRUS INFECTION IN PEDIATRIC PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANT: A SINGLE-CENTER RETROSPECTIVE STUDY
EHA Library, Anqi Zhou, 4208979
A SINGLE CENTRE 10 YEAR RETROSPECTIVE AUDIT ON USE OF HUMAN LEUKOCYTE ANTIGEN MATCHED PLATELET TRANSFUSIONS: USAGE, COST, WASTAGE AND EFFECTIVENESS
EHA Library, Shreyans Gandhi, 4208980
RNA‑SEQ–DRIVEN IDENTIFICATION OF LIPID REQUIREMENTS REVEALS LDL AS A KEY ENHANCER OF SCALABLE BMI‑1–TRANSDUCED CULTURED RBC PRODUCTION
EHA Library, Moira Lancelot, 4208981
A SINGLE CENTER AUDIT ON THE USE OF BLOOD PRODUCTS INCLUDING RED CELLS, PLATELETS, FRESH FROZEN PLASMA AND CRYOPRECIPITATE IN A TERTIARY NEONATAL UNIT- THE UNIVERSITY COLLEGE LONDON HOSPITAL
EHA Library, Devi Purushothaman, 4208982
TRANSFUSIONAL OPTIMIZATION IN LIVER TRANSPLANTATION USING VISCOELASTIC TEST GUIDED THERAPY, A USEFUL TOOL FOR PATIENT BLOOD MANAGEMENT
EHA Library, Jose Maria Garcia Gala, 4208984
ESTABLISHING EXPERT CONSENSUS ON DIAGNOSIS AND TREATMENT GUIDELINES FOR COLD AGGLUTININ DISEASE (CAD) – AN INTERNATIONAL DELPHI STUDY
EHA Library, Morie Gertz, 4208985
A DEDICATED BLOOD DONOR MANAGEMENT APPROACH TO ANEMIA: EFFECTS ON READMISSION TO DONATION
EHA Library, Carina Brito, 4208986
MODULATING MEGAKARYOPOIESIS: A HEAD-TO-HEAD COMPARISON OF RECOMBINANT TPO AND RECEPTOR AGONISTS ON MEGAKARYOCYTE DEVELOPMENT AND PLATELET OUTPUT​
EHA Library, SHUHONG HU, 4208987
IMMUNOMODULATORY EFFECTS OF ELTROMBOPAG ON CD8+ T CELLS IN IMMUNE THROMBOCYTOPENIA THROUGH IRON CHELATION
EHA Library, Michelle Tan, 4208990
REAL-WORLD CLINICAL BURDEN AMONG PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA WHO DEVELOPED RESISTANCE OR INTOLERANCE TO HYDROXYUREA
EHA Library, Evan Chen, 4208992
EFFICACY AND SAFETY OF HETROMBOPAG IN INCREASING PLATELET COUNTS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING HEPATECTOMY: A RANDOMIZED, PLACEBO-CONTROLLED STUDY
EHA Library, Ning Zhang, 4208994
CHARACTERIZING EARLY AND LATE RESPONDERS TO MULTI-IMMUNE MODULATOR RILZABRUTINIB IN PERSISTENT/CHRONIC IMMUNE THROMBOCYTOPENIA: FINDINGS FROM THE PHASE 3 LUNA3 STUDY
EHA Library, Nichola Cooper, 4208999
REAL-WORLD EFFECTIVENESS AND SAFETY OF A PREPARATION OF INTRAVENOUS IMMUNOGLOBULIN FOR IMMUNE THROMBOCYTOPENIA
EHA Library, Guillaume Moulis, 4209002
ADHERENCE TO DIAGNOSTIC GUIDELINES IN IMMUNE THROMBOCYTOPENIA: A 10-YEAR CLINICAL AUDIT AT A UK TERTIARY CENTER.
EHA Library, Lara D' Orleans Kapps, 4209003
EFFICACY AND SAFETY OF EFGARTIGIMOD IN PRIMARY IMMUNE THROMBOCYTOPENIA(ITP): META-ANALYSIS OF PHASE III RANDOMIZED CONTROLLED TRIALS
EHA Library, Mehak Dang, 4209004
ANTIBODY SPECIFICITY DETERMINES THE MECHANISM OF PLATELET DESTRUCTION IN ITP
EHA Library, Günalp Uzun, 4209005
RISK OF BLEEDING IN MANTLE CELL LYMPHOMA PATIENTS TREATED WITH COVALENT BRUTON TYROSINE KINASE INHIBITORS AND CONTEMPORARY ANTICOAGULANT OR ANTIPLATELET AGENTS: REAL-WORLD DATA INSIGHTS
EHA Library, Vladimir Otasevic, 4209008
A REAL-WORLD STUDY ON THE EFFICACY, SAFETY, AND UTILIZATION OF A CHINESE-DEVELOPED RECOMBINANT FACTOR VIII ( SCT800) FOR PROPHYLACTIC TREATMENT IN MODERATE TO SEVERE HAEMOPHILIA A PATIENTS
EHA Library, Feng Xue, 4209010
PHARMACOLOGIC INHIBITION OF THE APELIN RECEPTOR (APJ) IS PROTECTIVE IN MURINE MODELS OF HEREDITARY HEMORRHAGIC TELANGIECTASIA
EHA Library, Jaime Darce, 4209011
THROMBOELASTOGRAM-GUIDED BLEEDING RISK ASSESSMENT AND PERIOPERATIVE MANAGEMENT OF CONGENTIAL FACTOR VII DEFICIENCY
EHA Library, Kai Shen, 4209015
DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF CROVALIMAB FOR THE TREATMENT OF ACUTE VASO-OCCLUSIVE EPISODES IN SICKLE CELL DISEASE: RESULTS OF THE PHASE 1B CROSSWALK-A TRIAL
EHA Library, Satheesh Chonat, 4208919
CHANGING EPIDEMIOLOGY OF SICKLE CELL DISORDERS: GBD 2023 ANALYSIS OF INCIDENCE TRENDS TO 2023, REGIONAL DISPARITIES IN EUROPE, AND IMPLICATIONS FOR GENE THERAPY ACCESS
EHA Library, Tapan Giri, 4208921
DISTINCT CLINICAL PHENOTYPE OF HBSC GENOTYPE: LOWER SYSTEMIC COMPLICATION RATES BUT INCREASED RISK OF PROLIFERATIVE RETINOPATHY IN A LARGE PROSPECTIVE BRAZILIAN COHORT
EHA Library, Dahra Teles Soares Cruz, 4208923
BRIDGING GAPS IN SICKLE CELL DISEASE CARE: ERN-EUROBLOODNET’S COMPARATIVE ANALYSIS OF NATIONAL RECOMMENDATIONS ACROSS EUROPE
EHA Library, Anna Collado Gimbert, 4208927
LOWER INDEX OF MULTIPLE DEPRIVATION IS ASSOCIATED WITH GREATER IMPROVEMENT IN INFLUENZA VACCINATION IN ADULTS WITH SICKLE CELL DISEASE AND THALASSAEMIA: A PAIRED COHORT STUDY
EHA Library, Rose Ameli, 4208928
PREVALENCE AND CLINICAL IMPACT OF CLONAL HEMATOPOIESIS IN PATIENTS WITH BETA-THALASSEMIA
EHA Library, Simona Leoni, 4208930
COMBINED ATRIOVENTRICULAR COUPLING INDEX IN TRANSFUSION-DEPENDENT THALASSEMIA
EHA Library, Antonella Meloni, 4208931
ADVANCED GENE EDITING STRATEGIES FOR HEMOGLOBINOPATHIES: FROM FETAL HEMOGLOBIN REACTIVATION TO PRECISION PRIME EDITING
EHA Library, Safana Farooq, 4208932
IMPACT OF EMPAGLIFLOZIN ON THE OUTCOMES OF Β-THALASSEMIA MAJOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: THE THALEMPA OBSERVATIONAL STUDY
EHA Library, Anas Ibraheem, 4208934
SAFETY AND EXPECTED BENEFIT DRIVE GENE THERAPY ACCEPTANCE IN Β-THALASSEMIA AND SICKLE CELL DISEASE: A MULTICENTER MEDIATION ANALYSIS
EHA Library, Stefania Mistretta, 4208935
TRACKING MYOCARDIAL NATIVE T1 OVER TIME IN TRANSFUSION-DEPENDENT THALASSEMIA
EHA Library, Antonella Meloni, 4208937
ADJUNCT RESVERATROL OR OMEPRAZOLE IN NON-TRANSFUSION DEPENDENT THALASSEMIA PATIENTS WITH SECONDARY HEMOCHROMATOSIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
EHA Library, Thanapong Chopetgool, 4208939
REFINED CLASSIFICATION AND PHENOTYPE-DRIVEN ANALYSIS OF PIEZO1 VARIANTS REVEAL DOMAIN-SPECIFIC PATHOGENIC MECHANISMS
EHA Library, Barbara Eleni Rosato, 4208940
SEVERE ALAS2 DEFICIENCY REVEALS MITOCHONDRIAL AND METABOLIC DRIVERS OF X-LINKED SIDEROBLASTIC ANEMIA AND ENABLES GENE THERAPY RESCUE
EHA Library, Stefano Rivella, 4208941
THE VIBRANT TRIAL: A RANDOMIZED COMPARISON OF NASAL ANDINTRAVENOUS VITAMIN B12 SUPPLEMENTATION IN MACROCYTIC ANEMIA
EHA Library, Kundan Mishra, 4208942
ZANUBRUTINIB FOR THE TREATMENT OF COLD AGGLUTININ DISEASE: PRIMARY ANALYSIS OF THE PHASE II HOVON169 STUDY
EHA Library, Anne-Marie Becking, 4208943
DYNAMIC ANALYSIS OF GLUCOSE UTILIZATION IN RED BLOOD CELLS FROM PATIENTS WITH GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY
EHA Library, Titine Ruiter, 4208944
ADDITIONAL SAFETY AND EFFICACY RESULTS FROM HELIOS: A PHASE 2, OPEN-LABEL, LONG-TERM EXTENSION STUDY OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
EHA Library, Amy Dickey, 4208945
RETROSPECTIVE EVALUATION OF MOLECULAR GENETIC TESTING FOR PORPHYRIA PATIENTS IN A NATIONAL GENETICS LABORATORY
EHA Library, Dushy Navarajasegaran, 4208946
FIRST-LINE THERAPY IN WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA: REAL-WORLD OUTCOMES WITH ORAL CORTICOSTEROIDS ALONE OR COMBINED WITH RITUXIMAB
EHA Library, Gunnar Larfors, 4208947
PRECISE EDITING OF THE TFR2 GENE AS POSSIBLE THERAPEUTIC APPROACH FOR HEMOGLOBINOPATHIES
EHA Library, Antonella Nai, 4208950
THERAPEUTIC POTENTIAL OF SEVUPARIN IN CHRONIC KIDNEY DISEASE ANAEMIA: SYNERGISTIC EFFECTS WITH EPO AND MOLECULAR INSIGHTS INTO RENAL PROTECTION
EHA Library, Michela Asperti, 4208951
MANAGEMENT OF GENETIC HAEMOCHROMATOSIS IN NORTH LONDON’S LARGEST HOSPITAL. A SINGLE CENTRE REVIEW OF CURRENT CLINICAL PRACTICE.
EHA Library, Bharath Ram Sreedhar, 4208954
BEYOND GANZONI AND SIMPLIFIED DOSING TABLE: A PHYSIOLOGY-BASED INDIVIDUALIZED FORMULA FOR INTRAVENOUS IRON DOSING
EHA Library, Muhammet Özbilen, 4208955
ARE IRON-RICH DIETARY SUPPLEMENTS AS EFFECTIVE AS MEDICINAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA? A PROSPECTIVE STUDY OF LIPOSOMAL FERROUS BISGLYCINATE CHELATE
EHA Library, Nour Siala, 4208957
HEMASHIELD STUDY: INCIDENCE OF SEVERE INFECTIONS AND CMV REACTIVATION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH BISPECIFIC ANTIBODIES: A PROSPECTIVE STUDY.
EHA Library, Maria Stefania Infante, 4208959
ECTOPIC EBV INFECTION OF HEMATOPOIETIC STEM CELLS DRIVES T-CELL DIFFERENTIATION BLOCKADE VIA STAT2/IRF9-MEDIATED SENESCENCE
EHA Library, Zhuojun Liu, 4208961
RATES OF INFECTION IN PATIENTS (PTS) WITH B-CELL NON-HODGKIN LYMPHOMA (B-NHL): A REAL-WORLD ANALYSIS
EHA Library, Evgenii Shumilov, 4208963
MID‑REGIONAL PROADRENOMEDULLIN IDENTIFIES HIGH‑RISK INFECTIOUS AND TRANSPLANT‑RELATED COMPLICATIONS IN PEDIATRIC ALLOGENEIC HSCT: A PROSPECTIVE MULTICENTER STUDY
EHA Library, Manuela Spadea, 4208964
TORQUE TENO VIRUS: AN EMERGING BIOMARKER ASSOCIATED WITH ADVERSE PROGNOSIS AND THE RISK OF GRAFT-VERSUS-HOST DISEASE IN PATIENTS UNDERGOING ALLO-HSCT
EHA Library, Xiujuan Ma, 4208966
PRESERVED T-CELL FUNCTIONALITY COMPENSATES FOR HUMORAL DEFICIENCY IN SARS-COV-2 INFECTION DURING RITUXIMAB-CONTAINING CHEMOIMMUNOTHERAPY
EHA Library, Rong Wei, 4208969
CLINICAL AND PROGNOSTIC IMPLICATIONS OF HYPOGAMMAGLOBULINEMIA IN B-CELL NON-HODGKIN LYMPHOMA (B-NHL).
EHA Library, Amagoia Ruiz Martin, 4208971
USING S.SALIVARIUS PROBIOTIC TO PREVENT UPPER RESPIRATORY INFECTIONS IN RELAPSED-REFRACTORY MULTIPLE MYELOMA
EHA Library, Alessandra Romano, 4208972
VANCOMYCIN-RESISTANT ENTEROCOCCI COLONIZATION IN HEMATOLOGIC PATIENTS: IS IT STILL A PROBLEM? RESULTS OF A SURVEY AMONG THE CENTERS PARTICIPATING IN THE RETE EMATOLOGICA LOMBARDA (REL)
EHA Library, Chiara Cattaneo, 4208973
RISK FACTORS, CLINICAL OUTCOMES AND IMMUNE DYNAMICS OF CANDIDEMIA IN PATIENTS WITH HEMATOLOGICAL DISORDER
EHA Library, Zhangjie Chen, 4208974
OVERCOMING THE DIAGNOSTIC GRAY ZONE OF NEUTROPHIL CD64 IN HEMATOLOGICAL MALIGNANCIES USING THE MONOCYTE-TO-NEUTROPHIL CD64 EXPRESSION RATIO
EHA Library, Amane Tanaka, 4208975
MULTI-PHASE ASSESSMENT OF HYPOXIC RED BLOOD CELL STORAGE: FROM THE UNIT TO RECIPIENT-MIMICKING CONDITIONS
EHA Library, Vasileios Tzounakas, 4208983
LPC(16:0/0/0) DRIVES MACROPHAGE DYSFUNCTION IN ITP: A SYNERGISTIC DEXAMETHASONE-ATORVASTATIN THERAPY
EHA Library, Nan Jiang, 4208988
INTACT COVID-19 VACCINATION RESPONSE AND OVERALL SAFETY IN THE PHASE 3, MULTICENTER, DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL OF INTRAVENOUS EFGARTIGIMOD IN ITP (ADVANCE IV)
EHA Library, Monica Carpenedo, 4208989
BUDOPRUTUG, A LOW-FUCOSYLATED ANTI-CD19 MONOCLONAL ANTIBODY, IN ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: INITIAL PHASE 1B STUDY RESULTS
EHA Library, Edgar Charles, 4208991
COGNITIVE DYSFUNCTION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA (ITP): A CROSS-SECTIONAL OBSERVATIONAL STUDY
EHA Library, Nichola Cooper, 4208993
CLINICAL CHARACTERISTICS, TREATMENT STRATEGIES, AND RESPONSE PATTERNS IN EVANS SYNDROME: INITIAL ANALYSIS FROM THE SPANISH RESTI COHORT
EHA Library, María Eva Mingot Castellano, 4208995
AVATROMBOPAG IN TPO-RA–NAIVE ADULTS IN ACUTE, PERSISTENT, AND CHRONIC PHASES OF ITP: RESULTS FROM THE REAL-AVA 3.0 RETROSPECTIVE STUDY
EHA Library, Sandhya Panch, 4208996
BIOPRINTING A SILK-BASED 3D BONE MARROW MODEL FOR CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
EHA Library, Christian Di Buduo, 4208997
OUTCOME OF CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA ON LONG TERM ELTROMBOPAG OR ROMIPLOSTIM USE (SHIFT/TAPER-DISCONTINUE STUDY)
EHA Library, Tamer Hassan, 4208998
EFFECTS OF IANALUMAB TREATMENT ON B CELL ACTIVATION, MATURATION, AND MAINTENANCE OF VACCINE TITERS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN THE PHASE 2 VAYHIT3 STUDY
EHA Library, Thomas Stauch, 4209000
THYROID PEROXIDASE ANTIBODY IS ASSOCIATED WITH FAVORABLE RITUXIMAB RESPONSE IN ADULT IMMUNE THROMBOCYTOPENIA.
EHA Library, ruxia zhao, 4209001
HIGH PREVALENCE OF BLEEDING DISORDER OF UNKNOWN CAUSE IN WOMEN: FINDINGS FROM THE MAASTRICHT BLEEDING COHORT
EHA Library, Nienke Meskes, 4209006
COMPETING CAUSES OF DEATH IN HEMOPHILIA IN THE UNITED STATES: A NATIONAL MULTIPLE-CAUSE-OF-DEATH ANALYSIS, 2005–2024
EHA Library, Mohammad Ahsen Soomro, 4209007
EXPANDING ACCESS TO HEMOPHILIA CARE : SIGNIFICANT REDUCTION IN BLEEDING WITH LOW-DOSE EMICIZUMAB PROPHYLAXIS IN A PROSPECTIVE REAL-WORLD COHORT .
EHA Library, ADITI MALJI, 4209009
EVOLVING TREATMENT PRIORITIES IN HEMOPHILIA: PHYSICIAN AND PATIENT PERSPECTIVES ON CONVENIENCE, QUALITY OF LIFE, AND THE EMERGING ROLE OF REBALANCING AGENTS ACROSS THE US AND EU5
EHA Library, Sarah Hendry, 4209012
WHEN HYPOCOAGULABILITY MEETS THROMBOSIS: A SINGLE-CENTER COMPARATIVE STUDY OF CONGENITAL AND ACQUIRED PROTHROMBIN DEFICIENCY
EHA Library, Alfadil Haroon, 4209013
REDUCED ADAMTS13 ACTIVITY AND THROMBOTIC RISK IN NON-TTP CONDITIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
EHA Library, Stephanie Quon, 4209014

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings